Poland· PL-100159571
Fanipos
A fluticasone product containing fluticasoni propionas, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 14 of 19 countries.
Countries holding a registration under ATC R01AD08 (fluticasone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Fluticasone · ATC R01AD08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Fluticasoni propionas
- Manufacturer
- Teva Pharmaceuticals Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R01AD08
- ATC class
- Fluticasone
- Defined daily dose
- 0.2 mg, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
2 priced- gtin059082896603712 poj. po 120 daw.PLN 31.09
- gtin059099905707201 poj. po 120 daw.PLN 16.2
- gtin05909990570713
- gtin05909990570737
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for fluticasone.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
55 records
- 29 severe
- 25 moderate
- 1 minor
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- KetoconazoleH02CA03severe
- TroleandomycinJ01FA08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFlixonase 50 microgram per dosis, neusspray suspensieGlaxoSmithKline B.V.
- SpainFLIXONASE 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASALGlaxosmithkline (Ireland) Limited
- FinlandFlixonaseParanova Oy
- United StatesFluticasone PropionateAdvagen Pharma Ltd.
- IrelandFlixonase Allergy Relief 50 micrograms per dose Nasal SprayHaleon Ireland Limited
- SwitzerlandNasofan, Nasenspray, SuspensionMepha Pharma AG
- United KingdomAvamys 27.5micrograms/dose nasal sprayMawdsley-Brooks & Company Ltd
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a5357a81-b65b-42f6-9cef-511d3c33ac4b GET /v1/drugs/a5357a81-b65b-42f6-9cef-511d3c33ac4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do nosa, zawiesina",
"source": "urpl",
"strength": "50 mcg/dawkę donosową",
"packaging": "05909990570713 ¦ Rp ¦ 32373\n1 poj. 60 dawek\n05909990570720 ¦ Rp ¦ 32374\n1 poj. 120 dawek\n05909990570737 ¦ Rp ¦ 32376\n1 poj. 150 dawek\n05908289660371 ¦ Rp ¦ 118257\n2 poj. 120 dawek",
"substance": "Fluticasoni propionas 50 mcg/dawkę donosową",
"common_name": "Fluticasoni propionas",
"pl_product_id": "100159571",
"pozwolenie_nr": "12061",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.